Pharma in Focus
Email Address Sign-Up

Australia's most trusted source of pharma news

Contact Pharma in Focus

If you would like to know more about Pharma in Focus then write, email or phone us.

Postal Address: Suite 202
117 Old Pittwater Road
Brookvale NSW 2100
Advertising: +61 2 9938 4381
Editorial: +61 2 9939 0981
Subscriptions & Access: +61 2 9939 1881
Fax: +61 2 9938 5681
Email: info@pharmainfocus.com.au

If you would like specific information then please fill in the form below and send it to us.

Pipeline Monitor
New RA drug in view
A new rheumatoid arthritis drug from Sanofi and more good news for MSD on blockbuster Keytruda were highlights among pipeline decisions this week.
Perspective
MSD v PBAC: it's all about the data
It might have been short but MSD's statement on the revised draft report of the post-market review of ezetimibe spoke volumes on how treatment of PBS data can skew conclusions to potentially alarming effect.
Approvals Action
New hope for metabolic disease
Alexion's orphan therapy Kanuma has been approved by the TGA for metabolic disease lysomal acid lipase deficiency.